Safety and tolerability in relapsing-remitting multiple sclerosis patients treated with high-dose subcutaneous interferon-beta by Rebiject autoinjection over a 1-year period: the CoSa study (Q47666140)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and tolerability in relapsing-remitting multiple sclerosis patients treated with high-dose subcutaneous interferon-beta by Rebiject autoinjection over a 1-year period: the CoSa study |
scientific article |
Statements
1 reference
Safety and tolerability in relapsing-remitting multiple sclerosis patients treated with high-dose subcutaneous interferon-beta by Rebiject autoinjection over a 1-year period: the CoSa study (English)
1 reference
1 reference
1 reference
1 reference
Valentina Durastanti
1 reference
Marina Lai
1 reference
Carlo Pozzilli
1 reference
Stefano Sotgiu
1 reference
Bruno Ardito
1 reference
CoSa Study Group
1 reference
1 May 2008
1 reference
31
1 reference
3
1 reference
167-172
1 reference